AxoGen, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 10,947 7,692 4,849 3,004
Cost of Revenue 2,440 1,962 2,427 1,379
Gross Profit 8,508 5,730 2,423 1,626
Operating Expenses
Research and Development 2,125 1,427 697 436
Sales, General and Admin. 15,974 12,105 8,694 5,671
Non-Recurring Items - - - -
Other - - - -
Operating Income (9,592) (7,802) (6,969) (4,482)
Income From Continuing Operations
Add'l Income/Expense Items 34 24 67 1,196
Earnings Before Interest and Tax (9,558) (7,778) (6,901) (3,286)
Interest Expense 4,999 2,378 2,318 2,137
Earnings Before Tax (14,557) (10,156) (9,219) (5,423)
Income Tax - (738) - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (14,557) (9,418) (9,219) (5,423)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (14,557) (9,418) (9,219) (5,423)
Preferred Stock and Other Adjustments - - (1,028) (1,566)
Net Income Applicable to Common Shareholders (14,557) (9,418) (10,248) (6,990)